The current situation allows of no optimist to make a diagnosis in hemophilia

The current situation allows of no optimist to make a diagnosis in hemophilia
It is day of 22nd world hemophilia on April 17, the theme is to " take active action and make great efforts to realize everybody enjoys and treats " . The reporter in the theme interview of day of hemophilia that holds in one website on April 14 learns, so far, our country has already registered more than 7000 hemophilia cases, is still fewer than 1/10 of the total number of patients.
Hemophilia is a recessive heredity bleeding disease of a kind of X chromosome chain, initiate muscles, the joint, head or viscera to bleed, lead to the fact finally the normal activity is limited easily, even jeopardize the life. This be lasted methodded at present disease,last blood plasma, precipitating, blood coagulation factors cold or,etc. measures effective when lasting treatmenting.
China's hemophilia is treated and cooperated the person in charge of pediatrics group of group, centre Professor Wu RunHui of subsidiary hemophilia of BJ Children's Hospital of Capital University of Medical Sciences and introduced, BJ Children's Hospital counted 189 hemophilia infants coming to smaller than 6 years old at age going to a doctor recently, the result reveals, 90% of the children have not got any treatment while bleeding, 60%~70% of the children cause joint bleeding and intracranial hemorrhage because of the irregular treatment, it is important reasons that the medical insurance lacks and the therapeutic medicine is insufficient.
Centre director benevolence professor Chi Yang says that the thrombus of hospital of blood disease of the Chinese Academy of Medical Sciences is styptic to make a diagnosis, the factor output of blood coagulation of our country reached 400,000 bottles of ( 200IU) last year ,Have, rise obviously compared with the same period of the past two years, but quantity this have big gap from patient's demand, and the insufficient phenomenon of medicines is unlikely to solve in short term. The expert calls upon, should raise the production efficiency to blood products of enterprises, accelerate researching and developing efforts, and offer patients more guarantee in treating the expenses.
|